InsiderTrades

Form 4 for MRK Merck & Co.

Accepted 2022-11-10 00:00:00 ET · period of report 2022-11-08 · accession 0001127602-22-025313 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-11-10 2022-11-08+ MRK MIZELL STEVEN EVP, Chief HR Off S - Sale+OE $101.18 -35.0K 32.1K -52% -$3.54M
DM 2022-11-10 2022-11-08+ MRK MIZELL STEVEN EVP, Chief HR Off M - OptEx $0.00 +35.0K 52.1K +204% $0
DM 2022-11-10 2022-11-08+ MRK MIZELL STEVEN EVP, Chief HR Off M - OptEx $0.00 -35.0K 15.8K -69% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-11-10 S D 15,000 $101.42 32,144.15 D — — (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.4000 to $101.5300, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. (F2) Holdings include shares acquired in dividend reinvestment transactions.
2 Common Common Stock 2022-11-10 M A 15,000 $0.00 47,144.15 D — —
3 Common Common Stock 2022-11-08 M A 20,000 $0.00 52,144.15 D — —
4 Common Common Stock 2022-11-08 S D 20,000 $101.00 32,144.15 D — —
5 Derivative Stock Option (Right to Buy) 2022-11-10 M D 15,000 $0.00 824 D $70.71 · 2019-10-30 to 2028-10-29 15,000 Common Stock (F3) The option vested and became exercisable in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.
6 Derivative Stock Option (Right to Buy) 2022-11-08 M D 20,000 $0.00 15,824 D $70.71 · 2019-10-30 to 2028-10-29 20,000 Common Stock (F3) The option vested and became exercisable in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.